Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen

FASEB Journal

Volumn 15, Issue 13, 2001, Pages 2365-2376

  Chavakis, Triantafyllos ^a   Kanse, Sandip M ^a   Pixley, Robin A ^b   May, Andreas E ^c   Isordia Salas, Irma ^b   Colman, Robert W ^b   Preissner, Klaus T ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

HK; Leukocyte; Mac 1; Monoclonal antibody

Indexed keywords

BETA1 INTEGRIN; BETA2 INTEGRIN; BRADYKININ RECEPTOR; CD11B ANTIGEN; CD18 ANTIGEN; HIGH MOLECULAR WEIGHT KININOGEN; INTERCELLULAR ADHESION MOLECULE 1; KALLIKREIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; POLYPEPTIDE; THIOGLYCOLIC ACID; UNCLASSIFIED DRUG; UROKINASE RECEPTOR; VITRONECTIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL INTERACTION; ENDOTHELIUM CELL; FIBRINOGEN METABOLISM; GENE DISRUPTION; IMMOBILIZED CELL; INFLAMMATION; KALLIKREIN KININ SYSTEM; LEUKOCYTE ACTIVATION; MOLECULAR WEIGHT; MONOCYTE; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PERITONITIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN INTERACTION; VASODILATATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BINDING, COMPETITIVE; CELL ADHESION; CELL LINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBRINOGEN; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; K562 CELLS; KININOGEN, HIGH-MOLECULAR-WEIGHT; LEUKOCYTES; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MACROPHAGE-1 ANTIGEN; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; NEUTROPHIL INFILTRATION; PEPTIDES; PERITONITIS; PLASMIDS; THIOGLYCOLATES; U937 CELLS;

EID: 0035172074     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-0201com     Document Type: Article

References (56)

1. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
2. Leukocyte-endothelial adhesion molecules
3. Molecular mechanisms of zinc-dependent leukocyte adhesion involving the urokinase receptor and β2-integrins
4. Leukocyte adhesion: CD11/CD18 integrins and intercellular adhesion molecules
5. Occupancy of CD11b/CD18 (Mac-1) divalent ion binding sites(s) induce leukocyte adhesion
6. Leukocyte integrins
7. Urokinase-receptor and integrin partnership: Coordination of signaling for cell adhesion, migration and growth
8. Urokinase receptor: A molecular organizer in cellular communication
9. Urokinase plasminogen activator receptor, β2-integrins, and scr-kinases within a single receptor complex of human monocytes
10. The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes
11. Urokinase receptor (CD87) regulates leukocyte recruitment via β2-integrins in vivo
12. Identification of the urokinase receptor as an adhesion receptor for vitronectin
13. Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells
14. Identification of the binding site for plasma prekallikrein in human high molecular weight kininogen. A region from residues 185 to 224 of the kininogen light chain retains full binding activity
15. High molecular weight kininogen is an inhibitor of platelet calpain
16. Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein
17. Effects of chemical modifications on the surface- and protein-binding properties of the light chain of human high molecular weight kininogen
18. Binding of heparin to human high molecular weight kininogen
19. The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface
20. High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells
21. Identification of an endothelial cell binding site on kininogen domain D3
22. Mapping the cell binding site on high molecular weight kininogen domain 5
23. High molecular weight kininogen peptides inhibit the formation of kallikrein on endothelial cell surfaces and subsequent urokinase-dependent plasmin formation
24. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor
25. Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells
26. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells: Identity with the gC1q receptor
27. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: Identity with the receptor that binds to the globular 'heads' of C1q (gC1qR)
28. Inhibition of cell adhesion by high molecular weight kininogen
29. Opposing effects of low and high molecular weight kininogens on cell adhesion
30. Neutrophil adhesion on polyurethanes preadsorbed with high molecular weight kininogen
31. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions
32. High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets
33. High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5)
34. Cleaved high molecular weight kininogen binds directly to the integrin CD11b/CD18 (Mac-1) and blocks adhesion to fibrinogen and ICAM-1
35. Deletion mutagenesis of high molecular weight kininogen light chain identification of two anionic surface binding subdomains
36. The urokinase receptor is a major vitronectin binding protein on endothelial cells
37. Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes
38. Only simultaneous blocking of the L- and P-selectin completely inhibits neutrophil migration into mouse peritoneum
39. The P-selectin glycoprotein ligand-1 is important for recruitment of neutrophils into inflamed mouse peritoneum
40. Domain 5 of high molecular weight kininogen (kinostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis
41. Structure and function of leukocyte integrins
42. A novel leukointegrin, alpha d beta 2, binds preferentially to ICAM-3
43. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro
44. LFA-1 is sufficient in mediating neutrophil emigration in MAC-1-deficient mice
45. Fitzgerald factor: A hitherto unrecognised coagulation factor
46. The skin window as a monitor of leukocytic functions in contact activation factor deficiencies in man
47. Three noncontiguous peptides comprise binding sites on high-molecular-weight kininogen to neutrophils
48. Neutrophil emigration in the skin, lungs, and peritoneum: Different requirements for CD11/CD18 revealed by CD18-deficient mice
49. The shape of high molecular weight kininogen
50. Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: Partial activity within domain 5
51. Complement receptor type three-dependent degradation of opsonized erythrocytes by mouse macrophages
52. The elevated natural killer sensitivity of targets carrying surface-attached C3 fragments require the availability of the iC3b receptor (CR3) on the effectors
53. The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor
54. Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: An alternative initiation of the coagulation cascade
55. Activation of Mac-1 (CD11b/ CD18)-bound factor X by released cathepsin G defines an alternative pathway of leukocyte initiation of coagulation
56. Recent advances in platelet-polymorphonuclear leukocyte interaction